These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities. Stuart WH Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719 [TBL] [Abstract][Full Text] [Related]
32. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis: 2-year follow-up (investigational new drug No. 65863). Gladstone DE; Peyster R; Baron E; Friedman-Urevich S; Sibony P; Melville P; Gottesman M Am J Ther; 2011 Jan; 18(1):23-30. PubMed ID: 19770795 [TBL] [Abstract][Full Text] [Related]
33. Current status and future prospective of immunointervention in multiple sclerosis. Cavaletti G Curr Med Chem; 2006; 13(19):2329-43. PubMed ID: 16918358 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. Wiendl H; Hohlfeld R BioDrugs; 2002; 16(3):183-200. PubMed ID: 12102646 [TBL] [Abstract][Full Text] [Related]